Products for Research Use Only
RegisterLogin

FGFR-IN-25

CAT: 0013-GTR19274781-01Size: 50 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19274781-01Size:50 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
FGFR-IN-25 (Compound 19E) is an FGFR inhibitor with IC50 values of 1.30 nM for FGFR1 and 0.85 nM for FGFR2, and also acts as a radiosensitizer. It effectively reduces the phosphorylation levels of FGFR1 and its downstream effectors, pAKT and pERK. FGFR-IN-25 exhibits broad-spectrum antitumor activity against gastric, colorectal, liver, breast, triple-negative breast cancers, and glioblastoma. When combined with radiation therapy, FGFR-IN-25 synergistically activates the ROS-Caspase-3-GSDME pathway, downregulates PD-L1 expression, and induces immunogenic cell death, thereby enhancing the antitumor effects.
Storage Conditions
-20°C
Notes
For research use only.

Related Products

CatalogName
GTR18775284-01FGFR Antibody
GTR18795193-01FGFR Antibody
GTR19263935-01FGFR-IN-21
GTR19258785-01FGFR-IN-17
GTR19212218-01FGFR-IN-9
GTR19186078-01FGFR-IN-4
GTR19185941-01FGFR-IN-2
GTR19240395-01FGFR-IN-16
GTR19235367-01FGFR-IN-13
GTR19274980-01FGFR-IN-24

Alternative Products

CatalogName
378470FGFR
BA8935-100FGFR-IN-1
HY-147621FGFR-IN-6
HY-168653FGFR-IN-15
HY-142921FGFR-IN-2
HY-163527FGFR-IN-13
HY-162577FGFR-IN-14
HY-147620FGFR-IN-5
HY-174268FGFR-IN-21
HY-172923FGFR-IN-20

Popular Products